Veteran researcher, vaccine mandate critic named acting NIH head

Matthew Memoli, who has conducted research on influenza and other viruses, was critical of the U.S. response to the Covid-19 pandemic.

January 24, 2025 Check out STAT+

Sponsored By

Support STAT's journalism today with 40% off of a STAT+ annual subscription. You'll gain unlimited access to award-winning journalism, premium data tools, event discounts, and more.

Charles Dharapak/AP Veteran researcher who was critical of U.S. response to Covid named acting NIH head Memoli, who heads a NIH clinical studies unit, clashed with Anthony Fauci over broad vaccine mandates during Covid, saying it would hinder natural immunity. By Eric Boodman and Anil Oza STAT+ | Trump freeze on NIH grant reviews alarms scientists, with long-term impact uncertain NIH grant freeze fuels fears about the Trump administration's long-term impact on medical and biotechnology innovation in the United States By Jonathan Wosen and Megan Molteni STAT+ | Novo Nordisk's next-generation obesity treatment shows promise in early study An injectable form of the drug amycretin, which is also being developed as a pill, helped patients lose a substantial amount of weight. By Andrew Joseph Cliff Owen/AP Trump ends Fauci's security detail and says he'd feel no responsibility if harm befell him Anthony Fauci is the latest in a string of former Trump aides-turned-critics to see their federal protection canceled despite ongoing threats. By Associated Press STAT+ | CMS withdraws appeal of UnitedHealth Medicare Advantage star ratings case The decision comes as Trump paused some federal work and could help UnitedHealth generate bigger profits from the taxpayer-funded program. By Bob Herman Q&A: Why low oxygen shows potential as therapy for some chronic diseases  Vamsi Mootha speaks about interest in hypoxia therapy, based on lab studies and observations from high altitudes of the India-China border. By Elizabeth Cooney Crystal Milner/STAT Opinion: What we learned after four years of offering street medicine By unlocking existing revenue streams, it is possible to meet the health care needs of the unhoused population. By Indu Subaiya and Benjamin Kaska STAT+ | Novo Nordisk is slammed by U.K. trade group for not disclosing payments to health and patient groups Between 2015 and 2022, the preliminary report found that Novo Nordisk misreported 65 payments worth $95 million to health and patient groups. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser